Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience (vol 128, pg 440, 2016)

被引：2
|
作者：
Morillo-Gutierrez, B.
Beier, R.
Rao, K.
机构：
来源：
BLOOD | 2016年 / 128卷 / 21期
关键词：
D O I：
10.1182/blood-2016-10-745455
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2585 / 2585
页数：1
相关论文
共 50 条
  • [21] Treosulfan-based conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases
    Suh, Jin Kyung
    Im, Ho Joon
    Kang, Sung Han
    Kim, Hyery
    Choi, Eun Seok
    Koh, Kyung-Nam
    BONE MARROW TRANSPLANTATION, 2022, 57 (04) : 681 - 684
  • [22] Treosulfan-based conditioning regimen for allogeneic transplantation in children congenital non-malignant disorders - retrospective study
    Wachowiak, J.
    Grund, G.
    Sykora, K-W.
    Wynn, R. F.
    Kowalczyk, J.
    Drabko, K.
    Smiers, F.
    Bredius, R. G. M.
    Veys, P.
    Chybicka, A.
    Kalwak, K.
    Steward, C.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S295 - S295
  • [23] Busulfan-Based and Treosulfan-Based Myeloablative Conditioning for Allogeneic Transplantation in Children with Thalassemia Major: a Single-Center Experience From Southern Turkey
    Aygunes, Utku
    Karagun, Barbaros Sahin
    Tuncel, Defne Ay
    Sasmaz, Hatice Ilgen
    Antmen, Bulent
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2023, 21 (11) : 883 - 892
  • [24] Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with sickle-cell disease
    Zecca, M.
    Lisini, D.
    Leoni, M. C.
    Bernardo, M. E.
    Mastronuzzi, A.
    Guerini, P.
    Ottonello, G.
    Zavras, N.
    Bonetti, F.
    Giorgiani, G.
    Locatelli, F.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S35 - S35
  • [25] TREOSULFAN-BASED CONDITIONING REGIMEN IN PEDIATRIC ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE SERIES OF SINGLE CENTER EXPERIENCE
    Sasmaz, Ilgen
    Antmen, Ali
    Aygunes, Utku
    Karagun, Barbaros
    Turksoy, Duygu
    BONE MARROW TRANSPLANTATION, 2024, 59 : 282 - 282
  • [26] A long-term retrospective analysis of treosulfan-based conditioning in comparison with standard conditioning regimen for allogeneic HSCT in patients with primary or therapy-related myelodysplastic syndrome
    Casper, J.
    Hilgendorf, I.
    Wolff, D.
    Gromke, T.
    Trenschel, R.
    Kordelas, L.
    Dischkowski, M.
    Steckel, N.
    Freund, M.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S213 - S213
  • [27] Treosulfan-based reduced toxicity conditioning for allogeneic BMT in children with refractory Langerhans cell histiocytosis -: report of two cases
    Pieczonka, A
    Wachowiak, J
    Boruczkowski, D
    Leda, M
    Jólkowska, J
    Witt, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S227 - S227
  • [28] Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience
    Slatter, Mary A.
    Rao, Kanchan
    Amrolia, Persis
    Flood, Terry
    Abinun, Mario
    Hambleton, Sophie
    Nademi, Zohreh
    Goulden, Nick
    Davies, Graham
    Qasim, Waseem
    Gaspar, Hubert B.
    Cant, Andrew
    Gennery, Andrew R.
    Veys, Paul
    BLOOD, 2011, 117 (16) : 4367 - 4375
  • [29] A long-term retrospective analysis of treosulfan-based conditioning in comparison to standard conditioning regimen for allogeneic hsct in patients with advanced indolent and aggressive non-Hodgkin lymphoma
    Trenschel, R.
    Casper, J.
    Gromke, T.
    Steckel, N. K.
    Kordelas, L.
    Ditschkowski, M.
    Wolff, D.
    Freund, M.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S245 - S245
  • [30] Retrospective study on treosulfan-based preparative regimen for allogeneic HSCT in children with haematological malignancies and high-risk of conventional regimen related toxicity
    Wachowiak, J
    Chybicka, A
    Kowalczyk, J
    Boruczkowski, D
    Wojcik, B
    Grund, G
    Drabko, K
    Leda, M
    Pieczonka, A
    Turkiewicz, D
    Kalwak, K
    Choma, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S261 - S261
12345